Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
The Open University is currently addressing 3 pending office actions in the Biotechnology & Pharmaceuticals sector. While these actions are distributed across 3 distinct examiners, they are all contained within 1 distinct art unit, suggesting a thematic consistency in the technology being examined. This structure indicates that while the university is dealing with multiple individuals, the underlying technical standards and art unit policies remain uniform. Practitioners should note that managing 3 distinct examiners within a single unit can lead to varied interpretations of the same technical field.
VANWORMER, SKYLAR K is the busiest examiner for the university with 1 pending office action. Because the pending actions are split among different examiners, the workload is distributed despite the concentration in a single art unit. The presence of the 1 pending office action with VANWORMER, SKYLAR K requires a specific tactical approach tailored to that examiner's history, even as the broader strategy remains focused on the standards of the single art unit involved.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VANWORMER, SKYLAR K | 1 | 46.9% | +28.1% |
| RICCI, CRAIG D | 1 | 53.5% | +52.7% |
| LOVE, TREVOR M | 1 | 43.0% | +26.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18265933 | COMBINATION THERAPY COMPRISING UNCARIA FOR TREATING ANXIETY AND DEPRESSION | RICCI, CRAIG D | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18008996 | SHAN-ZHA FOR THE TREATMENT OF DEPRESSION AND ANXIETY DISORDERS | LOVE, TREVOR M | 5d overdue |
| 18265933 | COMBINATION THERAPY COMPRISING UNCARIA FOR TREATING ANXIETY AND DEPRESSION | RICCI, CRAIG D | 12d |
| 18289470 | ANALOG ONLINE LEARNING CIRCUIT | VANWORMER, SKYLAR K | — |
| Art Unit | Apps |
|---|---|
| 1611 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18289470 | ANALOG ONLINE LEARNING CIRCUIT | VANWORMER, SKYLAR K | — | §103 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18265933 | COMBINATION THERAPY COMPRISING UNCARIA FOR TREATING ANXIETY AND DEPRESSION | RICCI, CRAIG D | 1611 | §102§103 | Final Rejection | 12d | Pending | Jun 07, 2023 |
| 18008996 | SHAN-ZHA FOR THE TREATMENT OF DEPRESSION AND ANXIETY DISORDERS | LOVE, TREVOR M | 1611 | §103 | Final Rejection | 5d overdue | Pending | Dec 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial